Novo Nordisk A/S (NVO) Q1 2025 Earnings Call Transcript

Novo Nordisk A/S (NVO) Q1 2025 Results Conference Call May 7, 2025 7:00 AM ET

Company Participants

Jacob Rode - Head of Investor Relations
Lars Jorgensen - President and Chief Executive Officer
David Moore - Executive Vice President, U.S. Operations and Global Business Development
Mike Doustdar - Executive VP of International Operations
Martin Holst Lange - Executive Vice President and Head of Development
Karsten Munk Knudsen - Executive Vice President and Chief Financial Officer

Conference Call Participants

Richard Vosser - JPMorgan Chase & Co.
James Quigley - Goldman Sachs
Peter Verdault - BNP Paribas
Martin Parkhoi - SEB
Michael Nedelcovych - TD Cowen
Sachin Jain - Bank of America Merrill Lynch
Jo Walton - UBS

Operator

Good day, and thank you for standing by. Welcome to the Q1 2025 Novo Nordisk A/S Earnings Conference Call. [Operator Instructions]. Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your first speaker today, Jacob Rode, Head of Investor Relations. Please go ahead, sir.

Jacob Rode

Thank you, and welcome to this Novo Nordisk Earnings call for the first 3 months of 2025. My name is Jacob Rode, and I'm the Head of Investor Relations at Novo Nordisk. And with me today, I have CEO of Novo Nordisk, Lars Jorgensen, Executive Vice President, U.S. Operations; Dave Moore, Executive Vice President, International Operations, Mike Doustdar, Executive Vice President and Head of Development, Martin Holst Lange; and finally, Chief Financial Officer, Karsten Munk Knudsen. All speakers will be available for the Q&A session.

Today's announcement and the slides for this call are available on our website, novonordisk.com. Please note that the call is being webcasted live, and a recording will be made available on our website as well. The call is scheduled to last 1 hour.